Nippon India Pharma Fund - Direct Plan Growth Plan
Nippon India Mutual Fund · FM: Sailesh Raj Bhan, Kinjal Desai, Amber Singhania · INF204K01I50 · Direct
NAV ₹641.98 AUM ₹9044 Cr as of 07 Aug 2026
Latest available portfolio · Retrieved: 8-Aug-2026 11:25 PM IST · Disclosure date not provided
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | -0.0% | +2.9% | +6.4% | +15.6% | +13.8% | +18.6% | +13.8% | 75/236 | — |
Equity allocation
97.61%
Debt allocation
0.00%
Cash / Liquid
2.39%
Other
0.00%
All Equity Holdings (35) latest available
| # | Company | Value (₹ Cr) | % of AUM |
|---|---|---|---|
| 1 | Sun Pharmaceuticals Industries Ltd | 1155.9 | 12.78% |
| 2 | Lupin Ltd | 673.5 | 7.45% |
| 3 | Dr Reddy's Laboratories Ltd | 603.9 | 6.68% |
| 4 | Cipla Ltd | 556.1 | 6.15% |
| 5 | Divi's Laboratories Ltd | 493.9 | 5.46% |
| 6 | Apollo Hospitals Enterprise Ltd | 476.5 | 5.27% |
| 7 | Mankind Pharma Ltd | 364.3 | 4.03% |
| 8 | Sai Life Sciences Ltd | 315.5 | 3.49% |
| 9 | Ajanta Pharma Ltd | 312.8 | 3.46% |
| 10 | Max Healthcare Institute Ltd Ordinary Shares | 300.2 | 3.32% |
| 11 | Medplus Health Services Ltd | 287.4 | 3.18% |
| 12 | Vijaya Diagnostic Centre Ltd | 253.2 | 2.80% |
| 13 | Thyrocare Technologies Ltd | 239.9 | 2.65% |
| 14 | Ipca Laboratories Ltd | 232.1 | 2.57% |
| 15 | GlaxoSmithKline Pharmaceuticals Ltd | 223.8 | 2.47% |
| 16 | Gland Pharma Ltd | 199.7 | 2.21% |
| 17 | Abbott India Ltd | 189.1 | 2.09% |
| 18 | Alkem Laboratories Ltd | 180.3 | 1.99% |
| 19 | Dr. Lal PathLabs Ltd | 167.6 | 1.85% |
| 20 | Narayana Hrudayalaya Ltd | 162.4 | 1.80% |
| 21 | Aurobindo Pharma Ltd | 158.3 | 1.75% |
| 22 | Syngene International Ltd | 153.9 | 1.70% |
| 23 | Pfizer Ltd | 141.3 | 1.56% |
| 24 | Emcure Pharmaceuticals Ltd | 137.0 | 1.52% |
| 25 | Fortis Healthcare Ltd | 128.8 | 1.42% |
| 26 | Suraksha Diagnostic Ltd | 106.3 | 1.18% |
| 27 | Sanofi Consumer Healthcare India Ltd | 98.2 | 1.09% |
| 28 | Akums Drugs and Pharmaceuticals Ltd | 92.8 | 1.03% |
| 29 | Piramal Pharma Ltd | 92.5 | 1.02% |
| 30 | Anthem Biosciences Ltd | 81.6 | 0.90% |
| 31 | Sanofi India Ltd | 78.4 | 0.87% |
| 32 | Biocon Ltd | 61.5 | 0.68% |
| 33 | AstraZeneca Pharma India Ltd | 51.5 | 0.57% |
| 34 | Indoco Remedies Ltd | 43.9 | 0.49% |
| 35 | Concord Biotech Ltd | 14.3 | 0.16% |
All disclosed equity positions are shown.